Firebrick Pharma Limited (ASX:FRE)
Australia flag Australia · Delayed Price · Currency is AUD
0.0640
+0.0020 (3.23%)
Jul 1, 2025, 3:10 PM AEST

Firebrick Pharma Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2019
14112745--
Upgrade
Market Cap Growth
46.33%-59.96%-38.95%---
Upgrade
Enterprise Value
13102241--
Upgrade
Last Close Price
0.060.060.150.27--
Upgrade
PS Ratio
12.713.981211.4541.30--
Upgrade
PB Ratio
9.605.1711.035.40--
Upgrade
P/TBV Ratio
9.605.1711.035.40--
Upgrade
EV/Sales Ratio
11.903.50993.5237.40--
Upgrade
Debt / Equity Ratio
-----0.14
Upgrade
Asset Turnover
0.601.020.000.210.350.56
Upgrade
Quick Ratio
3.316.104.9218.277.753.11
Upgrade
Current Ratio
4.437.195.1118.507.773.12
Upgrade
Return on Equity (ROE)
-111.71%-51.22%-126.49%-77.28%-251.89%-203.95%
Upgrade
Return on Assets (ROA)
-52.89%-25.33%-72.06%-41.82%-126.25%-102.32%
Upgrade
Return on Capital (ROIC)
-64.79%-29.73%-78.47%-44.65%-153.17%-118.72%
Upgrade
Earnings Yield
-11.99%-10.75%-24.90%-8.48%--
Upgrade
FCF Yield
-13.88%-21.44%-21.18%-9.46%--
Upgrade
Buyback Yield / Dilution
-10.34%-5.25%-45.98%-5.45%-265.19%-14.12%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.